| اسم المنتج |
Fluocinolone Acetonide |
| الاسم بالانجليزية |
Fluocinolone Acetonide; Fluocinolone acetonide [USAN:INN:JAN]; Neo-Synalar; 6-alpha,9-alpha-Difluoro-16-alpha-hydroxyprednisolone 16,17-acetonide; 6alpha,9-Difluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone; 6alpha,9alpha-Difluoro-16alpha-hydroxyprednisolone 16,17-acetonide; 6alpha-Fluorotriamcinolone acetonide; Acetonida de fluocinolona; Acetonida de fluocinolona [INN-Spanish]; Acetonide de fluocinolone; Acetonide de fluocinolone [INN-French]; CCRIS 3250; Coriphate; Cortiplastol; Derma-Smoothe/FS; Dermalar; Dermatin (steroid); FS; Flucinar; Flucort; Fluocet; Fluocinolonacetonidum; Fluocinolone 16,17-acetonide; Fluocinolone acetonide [DCIT]; Fluocinoloni acetonidum; Fluocinoloni acetonidum [INN-Latin]; Fluonid; Fluotrex; Fluovitif; Flupollon; Fluzon; HSDB 3083; Jellin; Localyn; Localyn Syntex; NSC 92339; Omniderm; Percutina; Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-; Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone; Prodermin; RS 1401AT; RS-1401 AT; Radiocin; Retisert; Sinalar; Synalar; Synalar-HP; Synamol; Synandone; Synandrone; Synemol; Synotic; Synsac; Tefunote; UNII-0CD5FD6S2M; Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone (8CI); (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one; (4aS,4bR,5S,6aS,6bS,10aS,10bS,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one; (4aS,4bR,5S,6aS,6bS,9aR,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
| الصيغة الجزيئية |
C24H30F2O6 |
| الوزن الجزيئي الغرامي |
452.4882 |
| InChI |
InChI=1/C24H30F2O6/c1-20(2)31-19-9-13-14-8-16(25)15-7-12(28)5-6-21(15,3)23(14,26)17(29)10-22(13,4)24(19,32-20)18(30)11-27/h5-7,13-14,16-17,19,27,29H,8-11H2,1-4H3/t13?,14?,16-,17-,19+,21-,22-,23-,24+/m0/s1 |
| إستراتيجية المساعدة القطرية |
67-73-2 |
| المفوضية الأوروبية رقم |
200-668-5 |
| بنية جزيئية |
|
| كثافة |
1.36g/cm3 |
| درجة الإنصهار |
267-269℃ |
| نقطة الغليان |
578.5°C at 760 mmHg |
| معامل الإنكسار |
1.577 |
| نقطة الوميض |
303.7°C |
| ضغط البخار |
8.57E-16mmHg at 25°C |
| علامات على البضائع الخطرة |
 Xn:Harmful;
|
| خطر المصطلحات |
R20/21/22:;
R36/37/38:;
R40:;
|
| شروط الأمن |
S22:;
S26:;
S36:;
|
|
